FR2839721B1 - Antigene polypeptidique induisant des anticorps neutralisant le vih - Google Patents

Antigene polypeptidique induisant des anticorps neutralisant le vih

Info

Publication number
FR2839721B1
FR2839721B1 FR0206062A FR0206062A FR2839721B1 FR 2839721 B1 FR2839721 B1 FR 2839721B1 FR 0206062 A FR0206062 A FR 0206062A FR 0206062 A FR0206062 A FR 0206062A FR 2839721 B1 FR2839721 B1 FR 2839721B1
Authority
FR
France
Prior art keywords
neutralizing antibodies
polypeptide antigen
hiv neutralizing
inducing hiv
antigen inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0206062A
Other languages
English (en)
Other versions
FR2839721A1 (fr
Inventor
Florence Boudet
Habib Raphaelle El
Tino Krell
Regis Sodoyer
Michel Chevalier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Priority to FR0206062A priority Critical patent/FR2839721B1/fr
Priority to PCT/FR2003/001439 priority patent/WO2003097676A1/fr
Priority to EP03752794A priority patent/EP1506224A1/fr
Priority to CA002485453A priority patent/CA2485453A1/fr
Priority to AU2003249403A priority patent/AU2003249403A1/en
Priority to US10/438,691 priority patent/US7056519B2/en
Publication of FR2839721A1 publication Critical patent/FR2839721A1/fr
Application granted granted Critical
Publication of FR2839721B1 publication Critical patent/FR2839721B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FR0206062A 2002-05-17 2002-05-17 Antigene polypeptidique induisant des anticorps neutralisant le vih Expired - Fee Related FR2839721B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0206062A FR2839721B1 (fr) 2002-05-17 2002-05-17 Antigene polypeptidique induisant des anticorps neutralisant le vih
PCT/FR2003/001439 WO2003097676A1 (fr) 2002-05-17 2003-05-12 Antigene polypeptidique des anticorps neutralisant le vih
EP03752794A EP1506224A1 (fr) 2002-05-17 2003-05-12 Antigene polypeptidique des anticorps neutralisant le vih
CA002485453A CA2485453A1 (fr) 2002-05-17 2003-05-12 Antigene polypeptidique des anticorps neutralisant le vih
AU2003249403A AU2003249403A1 (en) 2002-05-17 2003-05-12 Polypeptide antigen inducing hiv neutralizing antibodies
US10/438,691 US7056519B2 (en) 2002-05-17 2003-05-15 Methods for inducing HIV-neutralizing antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0206062A FR2839721B1 (fr) 2002-05-17 2002-05-17 Antigene polypeptidique induisant des anticorps neutralisant le vih

Publications (2)

Publication Number Publication Date
FR2839721A1 FR2839721A1 (fr) 2003-11-21
FR2839721B1 true FR2839721B1 (fr) 2005-02-11

Family

ID=29286562

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0206062A Expired - Fee Related FR2839721B1 (fr) 2002-05-17 2002-05-17 Antigene polypeptidique induisant des anticorps neutralisant le vih

Country Status (5)

Country Link
EP (1) EP1506224A1 (fr)
AU (1) AU2003249403A1 (fr)
CA (1) CA2485453A1 (fr)
FR (1) FR2839721B1 (fr)
WO (1) WO2003097676A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2078726A1 (fr) * 2008-01-09 2009-07-15 Vision 7 GmbH Peptides inhibiteurs à entrée HIV à sécrétion pour la thérapie des infections au HIV

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000040616A1 (fr) * 1999-01-08 2000-07-13 Panacos Pharmaceuticals, Inc. TECHNIQUES D'ELICITATION D'ANTICORPS NEUTRALISANTS CIBLANT gp41 DU VIH-1

Also Published As

Publication number Publication date
WO2003097676A1 (fr) 2003-11-27
EP1506224A1 (fr) 2005-02-16
FR2839721A1 (fr) 2003-11-21
AU2003249403A1 (en) 2003-12-02
CA2485453A1 (fr) 2003-11-27

Similar Documents

Publication Publication Date Title
IS7133A (is) Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
FR10C0050I2 (fr) Anticorps opgl
DK1699822T3 (da) IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf
ATE517855T1 (de) Antikörper gegen chemotaktische monozytenproteine
FR14C0007I2 (fr) Remodelage et glycoconjugaison de peptides
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
HUP0500444A3 (en) Hcv antigen/antibody combination assay
DK1406656T3 (da) Fremgangsmåder til administrering af anti-TNF-alfa-antistoffer
NO20033418L (no) Immunregulatoriske antistoffer og anvendelse derav
DE60238075D1 (de) Adjuvierte antigene meningokokkenzusammensetzungen
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
HK1096975A1 (en) Monoclonal antibody against influenza b virus and immunoassay instrument using the antibody
DE60210864D1 (de) Modifiziertes fluoreszentes Protein
DE60232862D1 (de) Rekombinantes pockenvirus für chimäre proteine des menschlichen immunschwächevirus
DK1164375T3 (da) Assay til antitransglutaminaseantistoffer
CY1105629T1 (el) Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv
ATE513564T1 (de) Immunogener rekombinanter antikörper
FR2839721B1 (fr) Antigene polypeptidique induisant des anticorps neutralisant le vih
MA27184A1 (fr) Dosage d'anticorps anti-ingap
FR2819256B1 (fr) Polypeptide induisant des anticorps neutralisant le vih
EP1578461A4 (fr) Vaccins contre la proteine tat de vih servant a generer des anticorps neutralisants
FI20011055A0 (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
FR2818648B1 (fr) Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20100129